# China Surpass Streamline Post-Market Study

> **NCT05544045** · — · TERMINATED · sponsor: **Stryker Neurovascular** · enrollment: 11 (actual)

## Conditions studied

- Aneurysm, Intracranial

## Interventions

- **DEVICE:** Surpass Streamline Flow Diverter System

## Key facts

- **NCT ID:** NCT05544045
- **Lead sponsor:** Stryker Neurovascular
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-06-03
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Slow Enrollment
- **Last updated:** 2025-02-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05544045

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05544045, "China Surpass Streamline Post-Market Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05544045. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*